Skip to main content

Table 3 Multivariate Cox regression analysis on 5-year overall and disease-free survival

From: High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients

Parameter

Overall survival

Disease-free survival

Hazard ratio

95% CI

P value

Hazard ratio

95% CI

P value

AUF1 (fibroblasts)

0.950

0.334–0.950

0.0315

0.634

0.634–0.426

0.0249

Tumor size

      

 T3

1.112

0.374–3.308

0.8480

0.403

0.174–0.931

0.0333

 T4

0.756

0.160–3.578

0.7242

0.711

0.202–2.500

0.5952

Age (> 50 years)

1.059

0.609–1.840

0.8392

0.2040

0.489–1.165

0.755

Stage

      

 IIIA

1.934

0.534–6.997

0.3148

4.827

1.856–12.550

0.0012

 IIIB

3.237

0.589–17.782

0.1765

3.789

0.970–14.796

0.0553

Grade

      

 G2

0.649

0.097–6.172

0.8100

0.641

0.150–2.738

0.5483

 G3

0.775

0.050–5.410

0.5862

0.743

0.172–3.215

0.6907

Lymph node

      

 N1

0.855

0.283–2.589

0.7821

0.661

0.310–1.406

0.2823

 N2

1.515

0.447–5.132

0.5049

0.890

0.387–2.048

0.7848

 N3

0.923

0.206–4.135

0.9162

0.623

0.217–1.785

0.3782

HR_ Status

      

 ER(+ve)/Her2(−ve)

0.433

0.182–1.030

0.0584

0.502

0.502–0.275

0.0249

 ER(−ve)/Her2(+ve)

1.353

0.714–2.564

0.3536

1.045

1.045–0.643

0.8594

 ER(−ve)/Her2(−ve)

1.113

0.584–2.123

0.7448

1.013

1.013–2.231

0.9586

AUF1 (cancer cells)

1.042

0.629–1.726

0.8742

0.937

0.646–1.359

0.7305

Tumor size

      

 T3

1.148

0.380–3.468

0.8071

0.427

0.182–1.001

0.0504

 T4

0.665

0.136–3.259

0.6150

0.736

0.202–2.681

0.6415

Age (> 50 years)

1.034

0.594–1.801

0.9051

0.734

0.475–1.134

0.1639

Stage

      

 IIIA

1.733

0.476–6.309

0.4041

4.327

1.652–11,335

0.0029

 IIIB

3.585

0.629–20.426

0.1505

3.573

0.884–14.443

0.0740

Grade

      

 G2

0.716

0.091–5.651

0.7515

0.676

0.158–2.892

0.5977

 G3

0.915

0.115–7.288

0.9330

0.818

0.189–3.546

0.7883

Lymph node

      

 N1

0.897

0.298–2.703

0.8467

0.701

0.330–1.488

0.3542

 N2

1.664

0.498–5.552

0.4078

0.976

0.428–2.226

0.9539

 N3

0.922

0.201–4.232

0.9167

0.668

0.232–1.925

0.4551

HR_ Status

      

 ER(+ve)/Her2(−ve)

0.466

0.196–1.104

0.0828

0.531

0.292–0.969

0.0390

 ER(−ve)/Her2(+ve)

1.444

0.763–2.731

0.2590

1.089

0.670–1.768

0.7317

 ER(−ve)/Her2(−ve)

1.162

0.608–2.220

0.6503

1.060

0.658–1.709

0.8104